Home LiteratureArticle Details
PMID: 3262586 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Production of an interleukin-1 inhibitor by cell line P388D1 murine macrophages stimulated with Haemophilus actinomycetemcomitans lipopolysaccharide.

Infection and immunity ·Vol. 56 ·No. 11 ·1988-11-00 ·Pages 2801-7

Nishihara T, Koga T, Hamada S

Abstract

Murine macrophages of the P388D1 cell line stimulated with lipopolysaccharide (LPS) from Haemophilus actinomycetemcomitans Y4 released an interleukin-1 (IL-1) inhibitor, as well as IL-1. Maximal IL-1 activity in culture supernatants was detected after 24 h of culture. On the other hand, IL-1 inhibitor activity reached a maximum level after 72 h of culture. An IL-1 inhibitor was partially purified from the culture supernatant of P388D1 cells stimulated with Y4 LPS for 72 h by ammonium sulfate precipitation, followed by Sephacryl S-200 gel chromatography. A 160-kilodalton peak inhibitory to IL-1 and a 14-kilodalton peak showing IL-1 activity were separated by Sephacryl S-200 column chromatography. The partially purified IL-1 inhibitor significantly suppressed the proliferation of C3H/HeJ murine thymocytes that had been induced with murine and human IL-1 in the presence of a submitogenic dose of concanavalin A. The IL-1 inhibitor more strongly suppressed human recombinant IL-1 beta than human recombinant IL-1 alpha. This inhibitory activity of the partially purified preparation was unaffected by the presence of trypsin inhibitor and the protease inhibitor aprotinin. The IL-1 inhibitor did not exhibit either IL-2 or IL-2 inhibitor activity. The inhibitor suppressed C3H/HeJ thymocyte proliferation induced by IL-1 in the presence of a saturated concentration of IL-2 instead of a suboptimal concentration of concanavalin A. These results indicate that prolonged culture of Y4 LPS-stimulated murine macrophages releases a specific inhibitor of IL-1.

MeSH Terms
Animals Cell Line Haemophilus/immunology In Vitro Techniques Interleukin-1/antagonists & inhibitors,metabolism Lymphocyte Activation/drug effects Lymphokines/analysis,pharmacology Macrophage Activation Macrophages/physiology Mice Protease Inhibitors/pharmacology Time Factors
Chemicals
Interleukin-1 Lymphokines Protease Inhibitors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Nishihara T
Department of Dental Research, National Institute of Health, Tokyo, Japan.
Koga T
Hamada S
References (41)
41 references, click to expand
  1. Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1.
    J Immunol. 1977 Dec;119(6):2060-6 PMID: 915291
  2. Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines.
    Cell Immunol. 1977 Dec;34(2):416-9 PMID: 563294
  3. Long term culture of tumour-specific cytotoxic T cells.
    Nature. 1977 Jul 14;268(5616):154-6 PMID: 145543
  4. Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses.
    J Immunol. 1978 Oct;121(4):1353-60 PMID: 308962
  5. Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor.
    Cell Immunol. 1980 Mar 1;50(1):71-81 PMID: 6967358
  6. Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (Interleukin 1).
    Mol Immunol. 1980 May;17(5):571-7 PMID: 6971397
  7. Radioimmunologic determination of 15-keto-13,14-dihydro-PGE2: a method for its stable degradation product, 11-deoxy-15-keto-13,14-dihydro-11 beta, 16 xi-cyclo-PGE2.
    Methods Enzymol. 1982;86:306-20 PMID: 7132761
  8. The bone-resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Capnocytophaga ochracea isolated from human mouths.
    Arch Oral Biol. 1984;29(1):59-63 PMID: 6362631
  9. Identification of a specific interleukin 1 inhibitor in the urine of febrile patients.
    J Exp Med. 1984 Jan 1;159(1):126-36 PMID: 6607312
  10. Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction.
    J Dent Res. 1984 Mar;63(3):412-21 PMID: 6583243
  11. Interleukin-1.
    Rev Infect Dis. 1984 Jan-Feb;6(1):51-95 PMID: 6369481
  12. Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line.
    J Exp Med. 1984 Jun 1;159(6):1637-52 PMID: 6327874
  13. Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons.
    J Immunol. 1985 Jan;134(1):350-7 PMID: 2578047
  14. Biochemical and immunobiological properties of lipopolysaccharide (LPS) from Bacteroides gingivalis and comparison with LPS from Escherichia coli.
    Infect Immun. 1985 Mar;47(3):638-47 PMID: 3882561
  15. Actinobacillus actinomycetemcomitans in human periodontal disease.
    J Clin Periodontol. 1985 Jan;12(1):1-20 PMID: 3882766
  16. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor.
    J Immunol. 1985 Jun;134(6):3868-75 PMID: 2985700
  17. Characterization of a human interleukin 1 inhibitor.
    J Immunol. 1985 Jun;134(6):3882-6 PMID: 3872905
  18. Uromodulin: a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women.
    Science. 1985 Aug 2;229(4712):479-81 PMID: 2409603
  19. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.
    J Immunol. 1985 Oct;135(4):2562-8 PMID: 3875658
  20. Interleukin 1: an immunological perspective.
    Annu Rev Immunol. 1985;3:263-87 PMID: 2933048
  21. Spontaneous production of a suppressor factor by the human macrophage-like cell line U937. I. Suppression of interleukin 1, interleukin 2, and mitogen-induced blastogenesis in mouse thymocytes.
    J Immunol. 1986 Jan;136(1):181-5 PMID: 3484389
  22. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.
    Nature. 1986 Feb 6-12;319(6053):516-8 PMID: 3511389
  23. Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro.
    J Immunol. 1986 Apr 1;136(7):2478-82 PMID: 3081643
  24. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity.
    J Exp Med. 1986 Mar 1;163(3):511-9 PMID: 3485170
  25. Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.
    J Immunol. 1986 May 15;136(10):3643-8 PMID: 3009609
  26. Normal human neutrophils are a source of a specific interleukin 1 inhibitor.
    J Immunol. 1986 May 15;136(10):3686-92 PMID: 3486218
  27. Inhibition of interleukin 1 activity by a factor in submandibular glands of rats.
    J Immunol. 1986 Oct 1;137(7):2245-51 PMID: 3489762
  28. Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1.
    Proc Natl Acad Sci U S A. 1986 Dec;83(23):9119-23 PMID: 3538018
  29. Interleukin 1 inhibitor masks high interleukin 1 production in acquired immunodeficiency syndrome (AIDS).
    Clin Immunol Immunopathol. 1987 Jan;42(1):133-40 PMID: 3491712
  30. Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2.
    Am Rev Respir Dis. 1987 Jan;135(1):72-7 PMID: 3492161
  31. Recombinant human interleukin 1 alpha and beta stimulate mouse osteoblast-like cells (MC3T3-E1) to produce macrophage-colony stimulating activity and prostaglandin E2.
    Biochem Biophys Res Commun. 1986 Nov 26;141(1):285-91 PMID: 3492202
  32. Multiple biological properties of recombinant human interleukin 1 (beta).
    Immunobiology. 1986 Sep;172(3-5):301-15 PMID: 3100431
  33. UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activity.
    J Immunol. 1987 Mar 1;138(5):1457-63 PMID: 3492552
  34. A new assay for interleukin-1 in the presence of interleukin-2.
    J Immunol Methods. 1987 May 4;99(1):47-52 PMID: 3106502
  35. Extracellular proteinaceous substances from Haemophilus actinomycetemcomitans induce mitogenic responses in murine lymphocytes.
    Oral Microbiol Immunol. 1987 Mar;2(1):48-52 PMID: 3473422
  36. Isolation and purification of ILS, an interleukin 1 inhibitor produced by human gingival epithelial cells.
    Clin Exp Immunol. 1987 May;68(2):366-74 PMID: 3498574
  37. Bioassay for interleukin-1 inhibitors.
    J Immunol Methods. 1987 Sep 24;102(2):283-4 PMID: 3498773
  38. Clinical immunologic and microbiologic features of active disease sites in juvenile periodontitis.
    J Clin Periodontol. 1987 Oct;14(9):534-40 PMID: 3316298
  39. Human urine-derived inhibitors of interleukin 1.
    Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S594-8 PMID: 3317752
  40. Suppression of murine macrophage interleukin-1 release by the polysaccharide portion of Haemophilus actinomycetemcomitans lipopolysaccharide.
    Infect Immun. 1988 Mar;56(3):619-25 PMID: 3257748
  41. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1988-11-00
Pages
2801-7
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC259653
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com